Inventor
JAYARAMAN MUTHUSAMY
US67 patents
⚠️ This page may combine multiple inventors who share the name “JAYARAMAN MUTHUSAMY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
20 patentsUS11246933B1Feb 15, 2022
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC30 citations98
US10369226B2Aug 6, 2019
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC25 citations98
US9061063B2Jun 23, 2015
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC41 citations98
US11679158B2Jun 20, 2023
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC7 citations94
US11633479B2Apr 25, 2023
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC11 citations94
US11633480B2Apr 25, 2023
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC11 citations94
US11612657B2Mar 28, 2023
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC9 citations94
US11590229B2Feb 28, 2023
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC11 citations94
US11382979B2Jul 12, 2022
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC18 citations94
US9682922B2Jun 20, 2017
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC39 citations94
US11504391B1Nov 22, 2022
Modified RNA agents with reduced off-target effect
ALNYLAM PHARMACEUTICALS INC18 citations84
US11071784B2Jul 27, 2021
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC5 citations84
US10995336B2May 4, 2021
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC8 citations83
US10808246B2Oct 20, 2020
Oligonucleotide-ligand conjugates and process for their preparation
ALNYLAM PHARMACEUTICALS INC6 citations83
US12364762B2Jul 22, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US12350338B2Jul 8, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US12343398B2Jul 1, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US12239709B2Mar 4, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US11400158B2Aug 2, 2022
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC1 citations73
US9701623B2Jul 11, 2017
Di-aliphatic substituted pegylated lipids
ALNYLAM PHARMACEUTICALS INC5 citations73
ARBUTUS BIOPHARMA CORP
13 patentsUS9682139B2Jun 20, 2017
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP46 citations98
US9814777B2Nov 14, 2017
Targeting lipids
ARBUTUS BIOPHARMA CORP8 citations93
US10117941B2Nov 6, 2018
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP12 citations92
US9764036B2Sep 19, 2017
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP19 citations92
US11077197B2Aug 3, 2021
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP3 citations84
US10821186B2Nov 3, 2020
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP4 citations84
US10456473B2Oct 29, 2019
Lipid compositions
ARBUTUS BIOPHARMA CORP6 citations84
US9895448B2Feb 20, 2018
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
ARBUTUS BIOPHARMA CORP5 citations84
US9707292B2Jul 18, 2017
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP5 citations84
US12042541B2Jul 23, 2024
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP0 citations73
US11420931B2Aug 23, 2022
Lipid containing formulations
ARBUTUS BIOPHARMA CORP2 citations73
US10953095B2Mar 23, 2021
Lipid compositions
ARBUTUS BIOPHARMA CORP1 citations73
US9694077B2Jul 4, 2017
Lipid compositions
ARBUTUS BIOPHARMA CORP3 citations73
MANOHARAN MUTHIAH
11 patentsUS9186325B2Nov 17, 2015
Lipids and compositions for the delivery of therapeutics
MANOHARAN MUTHIAH100 citations99
US8999351B2Apr 7, 2015
Lipids and compositions for the delivery of therapeutics
MANOHARAN MUTHIAH102 citations99
US8883202B2Nov 11, 2014
Lipid compositions
MANOHARAN MUTHIAH104 citations99
US8642076B2Feb 4, 2014
Lipid containing formulations
MANOHARAN MUTHIAH155 citations99
US8575123B2Nov 5, 2013
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
MANOHARAN MUTHIAH82 citations98
US9012498B2Apr 21, 2015
Biodegradable lipids for the delivery of active agents
MANOHARAN MUTHIAH104 citations97
US9220683B2Dec 29, 2015
Lipids and compositions for the delivery of therapeutics
MANOHARAN MUTHIAH28 citations96
US8722082B2May 13, 2014
Lipids and compositions for the delivery of therapeutics
MANOHARAN MUTHIAH44 citations94
US9687550B2Jun 27, 2017
Compositions for nucleic acid delivery
MANOHARAN MUTHIAH21 citations93
US8507455B2Aug 13, 2013
Folate conjugates
MANOHARAN MUTHIAH32 citations92
US8962580B2Feb 24, 2015
Chemical modifications of monomers and oligonucleotides with cycloaddition
MANOHARAN MUTHIAH26 citations91
TEKMIRA PHARMACEUTICALS CORP
2 patentsCHEN JIANXIN
2 patentsUS HEALTH
1 patentRAJEEV KALLANTHOTTATHIL G
1 patentShowing the top 50 of 67 patents by PatentIndex Score.